MARC details
000 -LEADER |
fixed length control field |
05218cam a2200565Ii 4500 |
001 - CONTROL NUMBER |
control field |
ocn890935679 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20240729131657.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
fixed length control field |
m d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr cnu---unuuu |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
140919t20142014nyu ob 001 0 eng d |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
N$T |
019 ## - |
-- |
916949959 |
-- |
923676353 |
-- |
928195916 |
-- |
992886682 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
9781633215337 |
Qualifying information |
(electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
ISBN |
1633215334 |
Qualifying information |
(electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
9781633215108 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
1633215105 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
833077 |
-- |
(N$T) |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)890935679 |
Canceled/invalid control number |
(OCoLC)916949959 |
-- |
(OCoLC)923676353 |
-- |
(OCoLC)928195916 |
-- |
(OCoLC)992886682 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
071000 |
Source |
bisacsh |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
MAIN |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal author |
Fareed, Ayman. |
245 10 - TITLE STATEMENT |
Title |
Opioid use disorders and their treatment |
Statement of responsibility, etc |
|
Medium |
[E-Book] |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
New York : |
Name of producer, publisher, distributor, manufacturer |
Nova Science Publishers, Inc., |
Date of production, publication, distribution, manufacture, or copyright notice |
[2014] |
300 ## - PHYSICAL DESCRIPTION |
Physical description |
1 online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
490 1# - SERIES TITLE |
Series statement |
Substance abuse assessment, intervention and treatment |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
505 0# - CONTENTS |
Contents |
OPIOID USE DISORDERS AND THEIR TREATMENT; OPIOID USE DISORDERS AND THEIR TREATMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; Chapter 1: Diagnosing Opioid Use Disorder; References; Chapter 2: Opioid Craving and Anti-Craving Medications; Effect of Opioid Agonist Medications on Subjective and/or Objective Opioid Craving; Effect of Opiate Antagonist Medications on Subjective and/or Objective Opiate Craving; Effect of Dopamine Antagonist Medications on Subjective and/or Objective Opiate Craving. |
505 8# - CONTENTS |
Contents |
Effect of Other (Experimental) Medications on Subjective and/or Objective Opiate CravingConclusion; References; Chapter 3: Opioid Craving and Methadone; Effects of Methadone on Opioid Craving; Effect of Methadone Maintenance Treatment on Subjective Opiate Craving; Studies Which Reported Reduction of Heroin Craving for Patients in MMT; Studies Which Reported That Patients in MMT Are Still at Risk of Having Heroin Craving; Studies Which Reported Increase of Heroin Craving for Patients in MMT; Studies Which Reported That Methadone Has a Neutral Effect on Heroin Craving. |
505 8# - CONTENTS |
Contents |
Effect of Methadone Maintenance Treatment on Objective Measures of Opiate CravingStudies Which Reported Reduction of Heroin Craving for Patients in MMT; Studies Which Reported That Patients in MMT Are Still at Risk of Having Heroin Craving; Studies Which Reported an Increase of Heroin Craving for Patients in MMT; Studies Which Reported That Methadone Has a Neutral Effect on Heroin Craving; Studies Which Reported a Reduction of Heroin Craving for Patients in MMT; Studies Which Reported That Patients in MMT are Still at Risk of Having Heroin Craving. |
505 8# - CONTENTS |
Contents |
Studies Which Reported That Methadone Has a Neutral Effect or Could Increase Heroin CravingConclusion; References; Chapter 4: Faulty Decisions and Opioid Use Disorder; Conclusion; References; Chapter 5: Stress and Opioid Use Disorder; Conclusion; References; Chapter 6: Pain and Opioid Use Disorder; Conclusion; References; Chapter 7: Opioid Overdose Prevention and Treatment; Epidemiology; Pharmacokinetic Profile and Metabolism of Opioids; Signs and Symptoms of Intoxication, Overdose and Withdrawal; Diagnosis of Intoxication and Overdose. |
505 8# - CONTENTS |
Contents |
Treatment and Prevention of Intoxication and OverdoseHarm Reduction Programs; Conclusion; References; Chapter 8: Treatment of Opioid Withdrawal; Assessment of Opioid Withdrawal; Treatment of Opioid Withdrawal; Conclusion; References; Chapter 9: Methadone Maintenance Treatment; Induction/Stabilization on Methadone; Methadone Maintenance; Methadone Maintenance for Pregnant Women; Methadone Maintenance and Anti-HIV Medications; Conclusion; References; Chapter 10: Buprenorphine Maintenance Treatment; Induction, Stabilization and Maintenance Treatment with Buprenorphine. |
520 ## - ABSTRACT |
Abstract |
In this book, the reader will be updated about the most recent information related to opioid use disorders and how to treat them. It starts by providing information about how to diagnose these disorders, the mechanism of opioid craving as shown by subjective reporting scales and neuroimaging studies, and the relationship between opioid addiction and high risk behavior. It then describes the relationship between stress, chronic pain and opioid addiction, signs and symptoms of opioid overdose, how to prevent and treat it, and the implication of harm reduction programs to mitigate the risk of ove. |
590 ## - LOCAL NOTE (RLIN) |
Local note |
Master record variable field(s) change: 650 |
650 #0 - SUBJECT HEADINGS |
Subject term |
Opioid abuse. |
650 #0 - SUBJECT HEADINGS |
Subject term |
Substance abuse. |
9 (RLIN) |
8023 |
650 #0 - SUBJECT HEADINGS |
Subject term |
Substance abuse |
General subdivision |
Treatment. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Substance abuse assessment, interventions and treatment series. |
856 ## - ONLINE RESOURCE |
Uniform Resource Identifier |
<a href="#gotoholdings">#gotoholdings</a> |
Link text |
Access resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Suppress in OPAC |
Do not Suppress in OPAC |
588 0# - SOURCE OF DESCRIPTION NOTE |
Source of description note |
Print version record. |
938 ## - |
-- |
EBL - Ebook Library |
-- |
EBLB |
-- |
EBL2119931 |
938 ## - |
-- |
ebrary |
-- |
EBRY |
-- |
ebr10913173 |
938 ## - |
-- |
EBSCOhost |
-- |
EBSC |
-- |
833077 |
938 ## - |
-- |
YBP Library Services |
-- |
YANK |
-- |
12043885 |
994 ## - |
-- |
92 |
-- |
N$T |